Image

Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma

Study of Genetic and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma

Recruiting
18-80 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates unresectable pancreatic ductal adenocarcinoma. The purpose is to understand the complex interactions of genetic, stromal, and immunological factors in this condition.

The study evaluates how these factors may affect treatment response and chemotherapy resistance. It looks into genetic differences between primary and metastatic tumor sites and changes in molecular profiles under drug pressure.

  • Who can participate: Adults aged 18 to 79 years with a histological diagnosis of pancreatic ductal adenocarcinoma can participate. They must be fit for chemotherapy and willing to follow up at designated centers.
  • Study details: Participants will provide tissue samples via endoscopic ultrasound fine needle biopsy for analysis.
Print
Study details
    Pancreas Cancer

NCT05248750

Catholic University of the Sacred Heart

8 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.